0001123292-19-000436.txt : 20190305 0001123292-19-000436.hdr.sgml : 20190305 20190305180754 ACCESSION NUMBER: 0001123292-19-000436 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McElhaugh Michael J. CENTRAL INDEX KEY: 0001635326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 19660148 MAIL ADDRESS: STREET 1: C/O ONCORE BIOPHARMA, INC. STREET 2: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-03-01 0001447028 Arbutus Biopharma Corp ABUS 0001635326 McElhaugh Michael J. C/O ARBUTUS BIOPHARMA CORPORATION 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Business Officer Employee Stock Option (Right to Buy) 4.57 2019-03-01 4 A 0 104500 0 A 2029-03-01 Common Shares 104500 104500 D The option will vest and become exercisable in three equal annual installments beginning March 1, 2020. /s/ David C. Hastings, as attorney-in-fact for Michael J. McElhaugh 2019-03-05